查詢結果分析
來源資料
相關文獻
- Hepatitis C Virus and Hepatitis B Virus In Patients With Hepatocellular Carcinoma
- 醫療尖銳物品扎傷追蹤調查
- Immunopathogenesis of Viral Hepatitis B and C
- 兒童B型及C型肝炎病毒感染
- Occult Hepatitis B Virus Infection in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
- 表皮血管炎與感染性疾病
- 肝癌的流行病學
- Seroprevalence of Anti-HCV among Voluntary Blood Donors in Taiwan
- B型及C型肝炎盛行鄉內各村之間的盛行率差異:高雄縣梓官鄉之社區研究
- C型肝炎在雲嘉地區肝癌的重要性
頁籤選單縮合
題 名 | Hepatitis C Virus and Hepatitis B Virus In Patients With Hepatocellular Carcinoma=C型肝炎病毒感染,B型肝炎病毒感染與肝癌之關係 |
---|---|
作 者 | 唐鴻舜; 曹為麟; 趙有誠; 許重得; 廖炎智; 徐榮源; 謝財源; 謝忠平; 吳國良; | 書刊名 | 醫學研究 |
卷 期 | 13:6 1993.05[民82.05] |
頁 次 | 頁373-378 |
分類號 | 415.5332、415.5332 |
關鍵詞 | C型肝炎; 肝癌; B型肝炎; 病毒; 感染; |
語 文 | 英文(English) |
中文摘要 | 自C型肝炎病毒抗體(anti-HCV)標誌測試之可行,有關肝細胞癌與C型肝炎之關係,各家均有不同的研究結果,有認為HCV感染為主因,有認為HCV, HBV感染甚至HDV感染,有相加成作用,為探討此問題,本院做了以下回溯性研究。 190位肝癌病患,所有病患均符合下列兩者之一:(1)肝組織學檢查證實(2)經超音波或電腦斷層檢查且AFP>300 ng/ml, HBV標誌是利用Abbott RIA Kits, anti-HCV是利用Othro HCV AbELISA test。 結果:190位肝細胞癌病患,136位(71.6%)HBsAg陽性,35位(18.4%)anti-HCV陽性有9位(4.7%)兩者陽性反應,在54位HBsAg陰性肝癌患者26位(48.1%)為anti-HCV陽性,若比較HBsAg陽性組及anti-HCV陽性組,兩者間之年齡及性別有意義差別(52±15.4 Vs 64.3±9.0, p < 0.001及5.8 Vs 2.2, p < 0.05)。35位anti-HCV陽性組有26位(74.3%)OD值大於2.0且只有13位(37.1%)有輸血病史。 結論:肝細胞癌與HBsAg陽性有重要關聯性,佔71.6%。anti-HCV陽性只佔18.4%,在非乙型肝炎組中佔48.1%。有輸血者只佔37.1%,所以除輸血外,C型肝炎亦具有它傳染途徑值得研究。 |
英文摘要 | We studied the role of hepatitis B virus (HBV), and hepatitis C virus (HCV) infections in the pathogenesis of hepatocellular carcinoma (HCC) in 190 patients. Diagnosis of HCC was made if patients met either of the following diagnostic criteria: (a) histologically or cytologically confirmed HCC or (b) abdominal echo and/or computerized tomography imaging study positive with serum α-fetoprotein (AFP) higher than 300 ng/ml. HBV HCV were determined with markers of HBsAg and anti-HCV by using commercial immunoassays (About and Ortho). In the 190 patients with HCC, 136 (71.6%) were positive for HBsAg and 35 (18.4%) were positive for anti-HCV. Other results included 9 (4.7%) patients having both HBsAg and/or being anti-HCV positive, while 26 of 54 (48.1%) patients were HBsAg negative but positive for anti-HCV. By comparing both the mean age and male/female ratio between patients with HBsAg positive and anti-HCV positive, there were significantly differences. (52±15.4 vs 64.3±9.0 p<0.001, and 5.8 vs 2.2 p<0.05 respectively). Of the 35 anti-HCV positive patients, 26 (74.3%) had an optical density (OD) value which was over 2.0. Only thirteen (37.1%) of these patients had a history of blood transfusions. Our data confirms the high prevalence of HBsAg among patients with HCC (71.6%). Compared t other studies, anti-HCV in our patients was low (18.4% n total patients and 48.1% in HBsAg-negative patients). Since a history of blood transfusions was shown in only about 37.1% of the anti-HCV positive HCC patients, an additional mode of transmission for HCV must be considered. |
本系統中英文摘要資訊取自各篇刊載內容。